Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial

被引：0

作者：

Wei, Lai ^{[1
]}

Xie, Qing ^{[2
]}

Hou, Jinlin ^{[3
]}

Tang, Hong ^{[4
]}

Ning, Qin ^{[5
]}

Cheng, Jun ^{[6
]}

Nan, Yuemin ^{[7
]}

Zhang, Lunli ^{[8
]}

Li, Jun ^{[9
]}

Jiang, Jianning ^{[10
]}

McNabb, Brian L. ^{[11
]}

Zhang, Fangqiu ^{[12
]}

Camus, Gregory ^{[13
]}

Mo, Hongmei ^{[13
]}

McNally, John ^{[11
]}

Brainard, Diana M. ^{[11
]}

Subramanian, Mani ^{[11
]}

Gong, Guozhong ^{[14
]}

Mou, Zhuangbo ^{[15
]}

Wu, Shanming ^{[16
]}

Wang, Qui-Qiang ^{[17
]}

Hu, Peng ^{[18
]}

Gao, Yanhang ^{[19
]}

Jia, Jidong ^{[20
]}

Duan, Zhongping ^{[21
]}

机构：

[1] Peking Univ, Peoples Hosp, Beijing, Peoples R China

[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai, Peoples R China

[3] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China

[4] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China

[5] Huanzhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China

[6] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China

[7] Hebei Med Univ, Hosp 3, Shijiazhuang, Hebei, Peoples R China

[8] Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China

[9] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China

[10] Guangxi Med Univ, Affiliated Hosp 1, Guangxi, Peoples R China

[11] Gilead Sci Inc, Clin Res, 353 Lakeside Dr, Foster City, CA 94404 USA

[12] Gilead Sci Inc, Biostat, 353 Lakeside Dr, Foster City, CA 94404 USA

[13] Gilead Sci Inc, Virol, 353 Lakeside Dr, Foster City, CA 94404 USA

[14] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China

[15] Jinan Infect Dis Hosp, Jinan, Shandong, Peoples R China

[16] Clin Ctr Shanghai Publ Hlth, Shanghai, Peoples R China

[17] Peking Univ, Hosp 1, Beijing, Peoples R China

[18] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China

[19] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China

[20] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China

[21] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China

来源：

HEPATOLOGY | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1191

引用

页码：642A / 642A

页数：1

共 50 条

[31] Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study [J].

Lai Wei ;

Qing Xie ;

Jin Lin Hou ;

Hong Tang ;

Qin Ning ;

Jun Cheng ;

Yuemin Nan ;

Lunli Zhang ;

Jun Li ;

Jianning Jiang ;

Brian McNabb ;

Fangqiu Zhang ;

Gregory Camus ;

Hongmei Mo ;

Anu Osinusi ;

Diana M. Brainard ;

Guozhong Gong ;

Zhuangbo Mou ;

Shanming Wu ;

Guiqiang Wang ;

Peng Hu ;

Yanhang Gao ;

Jidong Jia ;

Zhongping Duan .

Hepatology International, 2018, 12 :126-132

[32] Safety and Efficacy of 8-weeks Ledipasvir/Sofosbuvir Combination in Chronic Hepatitis C Genotype 4-Infected Patients [J].

Babatin, Mohamed ;

Alghamdi, Abdullah S. ;

Assiri, Abdullah ;

Aleladi, Haziz ;

Shoja, Hamad ;

Mogharbel, Mohaammed ;

Alsahafi, Ashwaq ;

Mahalawi, Wadad ;

Sanai, Faisl .

HEPATOLOGY, 2017, 66 :821A-821A

[33] Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1 [J].

Yoshinori Ozono ;

Kenji Nagata ;

Satoru Hasuike ;

Hisayoshi Iwakiri ;

Kenichi Nakamura ;

Mai Tsuchimochi ;

Yuri Yamada ;

Yuka Takaishi ;

Mitsue Sueta ;

Tadashi Miike ;

Yoshihiro Tahara ;

Shojiro Yamamoto ;

Kotaro Shide ;

Tomonori Hidaka ;

Yoko Kubuki ;

Kazunori Kusumoto ;

Toshimasa Ochiai ;

Junya Kato ;

Naoto Komada ;

Shuichi Hirono ;

Kazuo Kuroki ;

Masafumi Shigehira ;

Kazuya Shimoda .

World Journal of Hepatology, 2017, (36) :1340-1345

[34] Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis [J].

He, Qiu-Feng ;

Zhang, Qiong-Fang ;

Zhang, Da-Zhi .

DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (11) :3108-3117

[35] Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis [J].

Qiu-Feng He ;

Qiong-Fang Zhang ;

Da-Zhi Zhang .

Digestive Diseases and Sciences, 2016, 61 :3108-3117

[36] Safety and Efficacy of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Hepatitis C in Subjects Aged 65 Years or Older [J].

Saab, Sammy ;

Park, Sarah H. ;

Mizokami, Masashi ;

Omata, Masao ;

Mangia, Alessandra ;

Eggleton, Ed ;

Zhu, Yanni ;

Knox, Steven J. ;

Pang, Phil ;

Subramanian, Mani ;

Kowdley, Kris ;

Afdhal, Nezam H. .

HEPATOLOGY, 2016, 63 (04) :1112-1119

[37] Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in HCV genotype IV infected patients [J].

Wang, Bin-Qiao ;

Wang, Yong-Lin ;

Shi, Ke-Qing .

LIVER INTERNATIONAL, 2017, 37 (05) :765-765

[38] EFFICACY AND SAFETY OF SOFOSBUVIR BASED TREATMENTS IN GENOTYPE 3 AND 6 HCV PATIENTS IN SOUTH CHINA [J].

Jiang, Mengfeng ;

Su, Minghua ;

Long, Shiyu ;

Li, Linman ;

Liang, Dandan ;

Huang, Jinni .

HEPATOLOGY, 2022, 76 :S413-S414

[39] Safety and Efficacy of Velpatasvir and Sofosbuvir-based Regimens for the Treatment of HCV Genotype 1-6: Results of the HCV-TARGET Study [J].

Landis, Charles S. ;

Sulkowski, Mark S. ;

Reau, Nancy ;

Lutchman, Glen A. ;

Vainorius, Monika ;

Welzel, Tania M. ;

Zeuzem, Stefan ;

Khalili, Mandana ;

Nelson, David R. ;

Lok, Anna S. ;

Fried, Michael W. ;

Terrault, Norah .

HEPATOLOGY, 2017, 66 :587A-587A

[40] Safety and efficacy of the combination Sofosbuvir-Ledipasvir in HCV mono-infected patients from the French Cohort ANRS CO22 HEPATHER [J].

Pol, Stanislas .

HEPATOLOGY, 2017, 66 :582A-582A

← 1 2 3 4 5 →